Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas

Genes Chromosomes and Cancer

Volumn 16, Issue 2, 1996, Pages 138-143

  Raskind, Wendy H ^a   Conrad, Ernest U ^a   Matsushita, Mark ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHONDROSARCOMA; CHROMOSOME 10Q; CHROMOSOME 11; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 8; CHROMOSOME DELETION; CHROMOSOME MAP; CHROMOSOME MARKER; CONTROLLED STUDY; DNA POLYMORPHISM; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE RET; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BONE NEOPLASMS; CHONDROSARCOMA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 8; GENE DELETION; GENETIC MARKERS; GENOTYPE; HETEROZYGOTE; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0029682809     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199606)16:2<138::AID-GCC8>3.0.CO;2-0     Document Type: Article

References (65)

1. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CHCM, Cass DT, Chakravarti A (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4:821-830.
2. Attie T, Pelet A, Edery P, Eng C, Mulligan L, Amiel J, Boutrand L, Beldjord C, Nihoul-Fekete C, Munnich A, Ponder B, Lyonnet S (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4:1381-1386.
3. Bergerheim USRB, Kunimi K, Collins VP, Ekman P (1991) Deletion mapping of chromosomes 8, 10, and 16 in human prostate carcinoma. Genes Chromosom Cancer 3:215-220.
4. Beutow KH, Ludwigsen S, Scherpbier-Heddema T, Quillen J, Murray JC, Sheffield VC, Duyk GM, Weber JL, Weissenbach J, Gyapay G, Dib C, Vignal A, Morrissette J, Lathrop GM, White R, Matsunami N, Gerken S, Melis R, Albertsen H, Ward K, Plaetke R, Odelberg S, Ward D, Bray-Ward P, Menninger J, Lieman J, Desai T, Banks A (1994) Human genetic map. Genome maps V. Wall chart. Science 265:2055-2070.
5. Biondi A, Rambaldi A (1994) Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia. Stem Cells 12:394-401.
6. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M, Tourniaire J, Lenoir G, Romeo G (1995) RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10:2415-2419.
7. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, DellaPorta G, Pierotti M (1994) Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 54: 2979-2985.
8. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalkin JA, Epstein JI, Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
9. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P (1993) Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 67: 1262-1267.
10. Cho KR, Vogelstein B (1992) Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem Suppl 16G:137-141.
11. Cotran RS, Kumar V, Robbins SL (1989) The musculoskeletal system. In: Robbins' Pathologic Basis of Disease. Philadelphia: W.B. Saunders, pp 1340-1342.
12. Crist WM, Pui CH (1993) Clinical implications of cytogenetic and molecular analyses of pediatric acute lymphoblastic leukemia. Stem Cells 11:81-87.
13. Cropp CS, Champeme M-H, Lidereau R, Callahan R (1993) Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53: 5617-5619.
14. De Potter CR, Schelfhout AM (1995) The neu-protein and breast cancer. Virchows Arch 426:107-115.
15. De Vita VT Jr, Hellman S, Rosenberg SA (1989) Sarcomas of Bone Cancer. Principles and Practice of Oncology. Philadelphia: J.B. Lippincott, pp 1456-1459.
16. Dijkhuizen T, van den Berg E, Molenaar WM, Oosterhuis JW, Dam A, Wiersema J, Koops HS, de Jong B (1994) Cytogenetics as a tool in the histologic subclassification of chondrosarcomas. Cancer Genet Cytogenet 76:100-105.
17. Dorfman HD, Czerniak B (1995) Bone cancers. Cancer 75(Suppl 1):203-210.
18. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HPH, Pfragner R, Behmel A, Lorenzo ML, Stonehouse TJ, Ponder MA, Ponder BAJ (1995) Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosom Cancer 12:209-212.
19. Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on the histologic grading. Cancer 40:818-831.
20. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
21. Foulkes WD, Black DM, Stamp GWH, Solomon E, Trowsdale J (1993) Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer 54:220-225.
22. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89-93.
23. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y (1993) Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal cancer. Cancer Res 53:1172-1174.
24. Fults D, Brockmeyer D, Tullous M, Pedone CA, Cawthon RM (1992) P53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674-679.
25. Gauwerky CE, Croce CM (1993) Chromosomal translocations in leukaemia. Semin Cancer Biol 4:333-340.
26. ™ Human Genome Data Base (1990-) Data base online. Baltimore: Johns Hopkins University. Updated daily. GDB Data Type: Map. GDB ID: G00-636-62 (cited 11/8/95). Available from Internet: 〈URL:http://gdbwww.gdb.org/gdb/browser/docs/topq. html〉.
27. Godwin AK, Vanderveer L, Schultz DC, Lynch HT, Altomare DA, Buetow KH, Daly M, Getts LA, Masny A, Rosenblum N, Hogan M, Ozols RF, Hamilton TC (1994) A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Am J Hum Genet 55:666-677.
28. Gyapay G, Morissette, Vignal A, Dib C Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-94 Genethon human genetic linkage map. Nature Genet 7:246-339
29. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA (1994) Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
30. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M (1995) Hereditary multiple exostosis and chondrosarcoma: Linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosomes 11 and 8. Am J Hum Genet 56:1125-1131.
31. Hinrichs SH, Jaramillo MA, Gumerlock PH, Gardner MB, Lewis JP, Freeman AE (1985) Myxoid chondrosarcoma with a translocation involving chromosome 9 and 22. Cancer Genet Cytogenet 14:219-226.
32. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JWM, van Amstel HKP, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thryoid carcinoma. Nature 367:375-376.
33. James MR, Richard CW III, Schott J-J, Yousry C, Clark K, Bell J, Terwilliger JD, Hazan J, Dubay C, Vignal A, Agrapart M, Imai T, Nakamura Y, Polymeropoulos M, Weissenbach J, Cox DR, Lathrop GM (1994) A radiation hybrid map of 506 STS markers spannine human chromosome 11. Nature Genet 8:70-76.
34. Jones CE, Davis MB, Darling JL, Geddes JF, Thomas DG, Harding AE (1995) Loss of heterozygosity for DNA polymorphisms mapping to chromosomes 10 and 17 and prognosis in patients with gliomas. J Neurol Neurosurg Psychiatry 58:218-221.
35. Jones MH, Koi S, Fujimoto I, Hasumi K, Kato K, Nakamura Y (1994) Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosom Cancer 9:119-123.
36. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M, Larsson C (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92:169-174.
37. Kreicbergs A, Boquist L, Borssen B, Larson SE (1982) Prognostic factors in chondrosarcoma. Cancer 50:577-583.
38. Kunimi K, Bergerheim USR, Larson I-L, Ekman P, Collins VP (1991) Allelotyping of human prostate adenocarcmoma. Genomics 11:530-536.
39. Lairmore TC, Howe JR, Korte JA, Dilley WG, Aine L, Aine E, Wells SA Jr, Donis-Keller H (1991) Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics 9:181-192.
40. Landsvater RM, Mathew CGP, Smith BA, Marcus EM, TeMeerman GJ, Lips CJM, Geerdink RA, Nakamura Y, Ponder BAJ, Buys CHCM (1989) Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10. Genomics 4:246-250.
41. Lavau C, Dejean A (1994) The t(15;17) translocation in acute promyelocytic leukemia. Leukemia 8:1615-1621.
42. Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F (1990) Chromosomal rearrangements in chondromatous tumors. Cancer 65:242-248.
43. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313-326.
44. Matise TC, Perlin M, Chakravarti A (1994) Automated construction of genetic linkage maps using an expert system (MultiMap): A human genome linkage map. Nature Genet 6:384-390.
45. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, L Papi MP, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ (1993) Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
46. Mulligan LM, Eng C, Attie T, Lyonnet S, Marsh DJ, Hyland VJ, Robinson BG, Frilling A, Verellen-Dumoulin C, Safar A, Venter DJ, Munnich A, Ponder BAJ (1994) Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 3:2163-3167.
47. Nelkin BD, Nakamura Y, White RW, deBustros A, Herman J, Wells SA Jr, Baylin SB (1989) Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma. Cancer Res 49:4114-4119.
48. Ozisik YY, Meloni AM, Peier A, Altungoz O, Spanier SS, Zalupski MM, Leong SPL, Sandberg AA (1994) Cytogenetic findings in 19 malignant bone tumors. Cancer 74:2268-2275.
49. Peiffer SL, Herzog TJ, Tribume DJ, Mutch DG, Gersell DJ, Goodfellow PJ (1995) Allelic loss of sequences from the long arm ot chromosome 10 and replication errors in endometrial cancers. Cancer Res 55:1922-1926.
50. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237.
51. Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE (1980) Chondrosarcoma: A clinocopathologic statistical analysis. Cancer 45:149-157.
52. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149.
53. Raskind WH, Conrad EU, Chansky H, Matsushita M (1995) Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet 56:1132-1139.
54. Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML (1993) Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53:2386-2392.
55. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Crissman JD (1994) Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 54:3273-3277.
56. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, DiFiore PP (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383.
57. Schmale GA, Conrad EU, Raskind WH (1994) The natural history of hereditary multiple exostoses. J Bone Jt Surg 76-A:986-992.
58. Shen W-PV, Young RF, Walter BN, Choi BH, Smith M, Katz J (1990) Molecular analysis of a myxoid chondrosarcoma with rearrangements of chromosomes 10 and 22. Cancer Genet Cytogenet 45:207-215.
59. Spurr NK, Bryant SP, Attwood J, Nyberg K, Cox SA, Mills A, Bains R, Warne D, Cullin L, Povey S, et al. (1994) European Gene Mapping Project (EUROGEM): Genetic maps based on the CEPH reference families. Eur J Hum Genet 2:193-252.
60. Tunnacliffe A, Jackson MS, Gardner E, Love DR, Moore JK, Mole SE, Mulligan LM, Graham A, Finocchiaro G, Orstavik S, Ponder BAJ (1994) A multiple interval physical map of the pericentromeric region of human chromosome 10. Hum Genet 93:313-318.
61. Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA (1988) Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 30:145-150.
62. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y, Yamamuro T (1993) p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68:1134-1139.
63. Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, Al Saadi AA, Juliar JP, Jackson CE, Tashjian AH Jr (1973) C-cell hyperplasia preceding medullary thryoid carcinoma. N Engl J Med 289:437-441.
64. Ye Z, Wu JK, Darras BT (1993) Loss of heterozygosity for alleles on chromosome 10 in human brain tumours. Neurol Res 15:59-67.
65. Zalupski MM, Ensley JF, Ryan J, Selvaggi S, Baker LH, Wolman SR (1990) A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma. Cancer 66:1176-1182.